T1	Participants 350 378	Patients with stage IC-IV OC
T2	Participants 112 126	ovarian cancer
T3	Participants 601 637	Patients with complete response (CR)
T4	Participants 884 911	PD or death in 636 patients
T5	Participants 1090 1118	820 of 919 patients enrolled
